The utility of positron emission tomography in the evaluation of autoimmune hearing loss

Otology and Neurotology

Volumn 24, Issue 2, 2003, Pages 201-204

  Mazlumzadeh, Mehrdad ^a   Lowe, Val J ^a   Mullan, Brian P ^a   Fabry, David A ^a   McDonald, Thomas J ^a   Matteson, Eric L ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Autoimmune inner ear disease; Hearing loss; Positron emission tomography

Indexed keywords

HEAT SHOCK PROTEIN 70;

ADULT; AGED; ARTICLE; AUDIOMETRY; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DRUG MEGADOSE; FEMALE; HEARING LOSS; HUMAN; INNER EAR DISEASE; MALE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; AUTOIMMUNE DISEASES; COCHLEA; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HEARING LOSS, SENSORINEURAL; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; PREDNISONE; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED; VESTIBULE;

EID: 0037339742     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200303000-00012     Document Type: Article

References (27)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
2. Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: Association with anticardiolipin antibodies. Lupus 1997;6:540-2.
3. Veldman JE, Roord JJ, O'Connor AF, Shea JJ. Autoimmunity and inner ear disorder: An immune complex mediated sensorineural hearing loss. Laryngoscope 1984;94:501-7.
4. Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: Is there a relationship? J Clin Gastroenterol 1982;4:251-2.
5. Shea JJ. Autoimmune sensorineural hearing loss as an aggravating factor in Ménière's disease. Presented at the Barany Society Meeting, Basel, Switzerland, June 1982.
6. Hughes GB, Kinney SE, Barna BP. Autoimmune reactivity in Cogan's syndrome: A preliminary report. Otolaryngol Head Neck Surg 1983;91:24-32.
7. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Autoimmune reactivity in Ménière's disease: A preliminary report. Laryngoscope 1983;93:410-7.
8. Alleman AM, Dornhoffer JL, Arenberg IK, Walker PD. Demonstration of autoantibodies to the endolymphatic sac in Ménière's disease. Laryngoscope 1997;107:211-5.
9. Haynes BF, Pikus A, Kaiser-Kupfer MI, Fauchi AS. Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids. Arthritis Rheum 1981;24:501-3.
10. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope 1984;94:758-67.
11. Hirose K, Wener MH, Duckert LG. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999;109:1749-54.
12. Naumann A, Hempel JM, Schorn K. Detection of humoral immune response to inner ear proteins in patients with sensorineural hearing loss. Laryngol-Rhinol-Otol 2001;80:237-44.
13. Kiang JG, Tsokos GC. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 1998;80:183-201.
14. Porenta G. Positron emission tomography: Physics, instrumentation, and image analysis. Wien Klin Wochenschr 1994;10615:466-77.
15. Maisey M, Jeffery P. Clinical applications of positron emission tomography. Br J Clin Pract 1999;45:265-72.
16. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999;38:444-7.
17. Thornton AR, Raffin MJM. Speech discrimination scores modeled as a binomial variable. J Speech Hear Res 1978;21:507-18.
18. Raffin MJM, Thornton AR. Confidence levels for differences between speech-discrimination scores: A research note. J Speech Hear Res 1980;23:5-18.
19. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images of focal pulmonary abnormalities. J Nucl Med 1994;35:1771-6.
20. Grond M, von Kummer R, Sobesky J, Schmulling S, Heiss WD. Early computed-tomography abnormalities in acute stroke. Lancet 1997;350:1595-6.
21. Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M. Inflammatory bowel disease activity measured by positron emission tomography. Lancet 1997;350:262.
22. Lewis P, Griffin S, Marsden P, et al. Whole-body fluorine-18flurodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994;344:1265-6.
23. Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503-11.
24. Stoppe G, Wildhagen K, Seidel JW, et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990;40:304-8.
25. Wildhagen K, Meyer GJ, Stoppe G, Heintz P, Deicher H, Hundeshagen H. PET and MR imaging in a neuro-Behçet syndrome. Eur J Nucl Med 1989;15:764-6.
26. Otte A, Weiner SM, Hoegerle S, et al. Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: A FDG PET study. Lupus 1998;7:57-9.
27. Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K, Nagata K. Sequential PET studies in neuro-Behcet's syndrome. J Neurol 1989;236:367-70.